Description

This presentation explores the future of pain management through emerging neuromodulation technologies such as optogenetics, focused ultrasound, brain-computer interfaces, and AI-driven personalized therapies. The speaker outlines how real-time biomarkers and adaptive closed-loop systems could transform subjective pain assessment into objective, data-guided treatment. They also highlight early-stage companies already piloting these innovations, as well as funding avenues like SBIR grants and federal initiatives. Despite significant promise, challenges remain in funding, regulation, data security, and reimbursement. Ultimately, the talk encourages clinicians and innovators to anticipate a future where intelligent, personalized, and minimally invasive neuromodulation reshapes chronic pain care.